Ellen Hukkelhoven
Fortune : - $ au 30/06/2026
Fortune : - $ au 30/06/2026
Dr. Ellen Hukkelhoven is a Head of Investment Research at Perceptive Advisors (Private Equity) and a Head of Investment Research at Perceptive Advisors LLC.
She is on the Board of Directors at Partner Therapeutics, Inc., MeiraGTx Ltd., MeiraGTx Holdings Plc, AavantiBio, Inc., Freenome Holdings, Inc., KBI Services, Inc. and Mailman School of Public Health.
She focuses on public and private development stage therapeutic companies.
Dr. Hukkelhoven was previously employed as an Observer by Dynacure SA.
Dr. Hukkelhoven received her PhD in cancer biology from Memorial Sloan Kettering Cancer Center.
She also graduated from Princeton University with degrees in molecular biology and finance.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MEIRAGTX HOLDINGS PLC | Directeur/Membre du Conseil | 01/10/2017 |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Directeur de la Recherche - Actions | 01/03/2013 |
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics that improve health and economic outcomes in the treatment of cancer | Directeur/Membre du Conseil | 07/03/2018 |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Corporate Officer/Principal | 01/03/2013 |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders | Directeur/Membre du Conseil | 19/10/2017 |
Freenome Holdings, Inc.
Freenome Holdings, Inc. Medical SpecialtiesHealth Technology Operates as an early cancer detection company that develops blood-based screening tests | Directeur/Membre du Conseil | - |
KBI Services, Inc.
KBI Services, Inc. Medical/Nursing ServicesHealth Services Provides women healthcare and fertility services | Directeur/Membre du Conseil | - |
Mailman School of Public Health
Mailman School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Finance |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gerstner Sloan Kettering Graduate School of Biomedical Science
Gerstner Sloan Kettering Graduate School of Biomedical Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders | Health Technology |
Freenome Holdings, Inc.
Freenome Holdings, Inc. Medical SpecialtiesHealth Technology Operates as an early cancer detection company that develops blood-based screening tests | Health Technology |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Health Services |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Finance |
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics that improve health and economic outcomes in the treatment of cancer | Health Technology |
MeiraGTx Holdings Plc
MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
KBI Services, Inc.
KBI Services, Inc. Medical/Nursing ServicesHealth Services Provides women healthcare and fertility services | Health Services |
Mailman School of Public Health
Mailman School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national